GENELABS GETS $1.25 MILLION PAYMENT

Genelabs Technologies has received a $1.25 million license payment from Affymetrix. The money is part of an amendment to a license agreement between the two companies for Genelabs' DNA amplification technology, used in drug discovery.

San Francisco Business Times (http://www.bizjournals.com/sanfrancisco/stories/2004/12/27/daily29.html)